{"id":23157,"date":"2024-03-18T09:45:39","date_gmt":"2024-03-18T08:45:39","guid":{"rendered":"https:\/\/ggba.swiss\/alithea-genomics-embarks-on-next-phase-growth-with-chf-2-8-million-funding\/"},"modified":"2024-03-18T09:48:59","modified_gmt":"2024-03-18T08:48:59","slug":"alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/","title":{"rendered":"Alithea Genomics franchit une nouvelle \u00e9tape de croissance avec un financement de CHF 2,8 millions"},"content":{"rendered":"\n<p><a href=\"https:\/\/alitheagenomics.com\/\">Alithea Genomics<\/a>, r\u00e9put\u00e9e pour sa technologie pionni\u00e8re de s\u00e9quen\u00e7age et de codage de l&rsquo;ARN en bloc (BRB-seq), se fixe une s\u00e9rie d&rsquo;objectifs ambitieux, notamment le lancement de nouveaux produits de s\u00e9quen\u00e7age de l&rsquo;ARN, l&rsquo;augmentation de la capacit\u00e9 de production, le d\u00e9veloppement de technologies pionni\u00e8res et l&rsquo;\u00e9tablissement d&rsquo;une filiale aux \u00c9tats-Unis.<\/p>\n\n\n\n<p>La technologie BRB-seq de la soci\u00e9t\u00e9 repr\u00e9sente un changement de paradigme dans le s\u00e9quen\u00e7age de l&rsquo;ARN, offrant une alternative rentable et \u00e0 tr\u00e8s haut d\u00e9bit aux m\u00e9thodes traditionnelles. Cette approche innovante simplifie le processus de pr\u00e9paration des \u00e9chantillons et permet de traiter simultan\u00e9ment des centaines d&rsquo;\u00e9chantillons d&rsquo;ARN, acc\u00e9l\u00e9rant ainsi la recherche et la d\u00e9couverte de m\u00e9dicaments.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Un nouveau si\u00e8ge au c\u0153ur de la Health Valley<\/h4>\n\n\n\n<p>Dirig\u00e9 par <a href=\"https:\/\/noval.is\/\">Novalis Biotech<\/a> et rejoint par le nouvel investisseur <a href=\"https:\/\/techuventures.com\/\">TechU Ventures<\/a>, aux c\u00f4t\u00e9s des investisseurs historiques, le nouveau financement d&rsquo;un montant de CHF 2,8 millions catalysera la trajectoire commerciale d&rsquo;Alithea, avec des plans visant \u00e0 \u00e9largir la port\u00e9e de ses technologies r\u00e9volutionnaires BRB-seq et DRUG-seq. DRUG-seq, qui vient s&rsquo;ajouter au portefeuille d&rsquo;Alithea, \u00e9limine la n\u00e9cessit\u00e9 d&rsquo;isoler l&rsquo;ARN, offrant ainsi une voie simplifi\u00e9e pour les processus de d\u00e9veloppement de m\u00e9dicaments, et a d\u00e9j\u00e0 attir\u00e9 l&rsquo;attention d&rsquo;entit\u00e9s pharmaceutiques majeures.<\/p>\n\n\n\n<p>Avec l&rsquo;\u00e9tablissement d&rsquo;une filiale aux \u00c9tats-Unis, Alithea souhaite p\u00e9n\u00e9trer le lucratif march\u00e9 am\u00e9ricain, encourager les collaborations internationales et \u00e9tendre ses solutions innovantes \u00e0 un public plus large. En outre, l&rsquo;installation dans un nouveau si\u00e8ge \u00e0 Lausanne, \u00e9quip\u00e9 de laboratoires de pointe, vient renforcer les efforts d&rsquo;Alithea pour faire progresser le s\u00e9quen\u00e7age de l&rsquo;ARN.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La start-up lausannoise Alithea Genomics a annonc\u00e9 la cl\u00f4ture r\u00e9ussie d&rsquo;une extension de CHF 2,8 millions de son financement d&rsquo;amor\u00e7age, une \u00e9tape importante pour le d\u00e9veloppement des technologies de s\u00e9quen\u00e7age de l&rsquo;ARN.<\/p>\n","protected":false},"author":6,"featured_media":23154,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1210,1148,1141,1143],"class_list":["post-23157","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-diagnostic-fr-2","tag-financing-fr-2","tag-personalized-medicine-fr-2","tag-vaccines-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CHF 2,8 millions pour la croissance continue d&#039;Alithea Genomics<\/title>\n<meta name=\"description\" content=\"Alithea Genomics a annonc\u00e9 la cl\u00f4ture r\u00e9ussie d&#039;une extension de CHF 2,8 millions de son financement d&#039;amor\u00e7age.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CHF 2,8 millions pour la croissance continue d&#039;Alithea Genomics\" \/>\n<meta property=\"og:description\" content=\"Alithea Genomics a annonc\u00e9 la cl\u00f4ture r\u00e9ussie d&#039;une extension de CHF 2,8 millions de son financement d&#039;amor\u00e7age.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-18T08:45:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-18T08:48:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Alithea Genomics franchit une nouvelle \u00e9tape de croissance avec un financement de CHF 2,8 millions\",\"datePublished\":\"2024-03-18T08:45:39+00:00\",\"dateModified\":\"2024-03-18T08:48:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\"},\"wordCount\":318,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg\",\"keywords\":[\"Biotech\",\"Diagnostic\",\"Financing\",\"Personalized Medicine\",\"Vaccines\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\",\"name\":\"CHF 2,8 millions pour la croissance continue d'Alithea Genomics\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg\",\"datePublished\":\"2024-03-18T08:45:39+00:00\",\"dateModified\":\"2024-03-18T08:48:59+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Alithea Genomics a annonc\u00e9 la cl\u00f4ture r\u00e9ussie d'une extension de CHF 2,8 millions de son financement d'amor\u00e7age.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Alithea Genomics, n\u00e9e \u00e0 l'EPFL en 2020, s'est distingu\u00e9e dans le secteur des sciences de la vie avec ses solutions de s\u00e9quen\u00e7age de l'ARN \u00e0 la pointe de la technologie. | \u00a9 Alithea Genomics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alithea Genomics franchit une nouvelle \u00e9tape de croissance avec un financement de CHF 2,8 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CHF 2,8 millions pour la croissance continue d'Alithea Genomics","description":"Alithea Genomics a annonc\u00e9 la cl\u00f4ture r\u00e9ussie d'une extension de CHF 2,8 millions de son financement d'amor\u00e7age.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"CHF 2,8 millions pour la croissance continue d'Alithea Genomics","og_description":"Alithea Genomics a annonc\u00e9 la cl\u00f4ture r\u00e9ussie d'une extension de CHF 2,8 millions de son financement d'amor\u00e7age.","og_url":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-03-18T08:45:39+00:00","article_modified_time":"2024-03-18T08:48:59+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Alithea Genomics franchit une nouvelle \u00e9tape de croissance avec un financement de CHF 2,8 millions","datePublished":"2024-03-18T08:45:39+00:00","dateModified":"2024-03-18T08:48:59+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/"},"wordCount":318,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg","keywords":["Biotech","Diagnostic","Financing","Personalized Medicine","Vaccines"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/","url":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/","name":"CHF 2,8 millions pour la croissance continue d'Alithea Genomics","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg","datePublished":"2024-03-18T08:45:39+00:00","dateModified":"2024-03-18T08:48:59+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Alithea Genomics a annonc\u00e9 la cl\u00f4ture r\u00e9ussie d'une extension de CHF 2,8 millions de son financement d'amor\u00e7age.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Alithea-Genomics-BRB-seq-1180x811-1.jpeg","width":1180,"height":811,"caption":"Alithea Genomics, n\u00e9e \u00e0 l'EPFL en 2020, s'est distingu\u00e9e dans le secteur des sciences de la vie avec ses solutions de s\u00e9quen\u00e7age de l'ARN \u00e0 la pointe de la technologie. | \u00a9 Alithea Genomics"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Alithea Genomics franchit une nouvelle \u00e9tape de croissance avec un financement de CHF 2,8 millions"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=23157"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23157\/revisions"}],"predecessor-version":[{"id":23159,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23157\/revisions\/23159"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/23154"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=23157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=23157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=23157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}